3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Neoplasms
3
Colonic Neoplasms
3
Breast Neoplasms
3
Pain
2
Leiomyoma
2
Wounds and Injuries
1
Stomatitis
1
Postoperative Hemorrhage
1
Mucositis
1
Malignant Pleural Neoplasm
1
Inflammatory Bowel Diseases
1
Ileus
1
Head and Neck Neoplasms
1
Feeding and Eating Disorders
1
Diverticulitis
1
Colorectal Neoplasms
1
Cancer Pain
1
Agnosia
1
Interventions
Cisplatin
6
Radiotherapy, Intensity-Modulated
4
Saline Solution
3
Injections
3
golotimod
2
avasopasem manganese
2
Water
2
Vitamin B 12
2
Standard of Care
2
RRx-001
2
Practice Guidelines as Topic
2
Gentamicins
2
Fibroblast Growth Factor 7
2
FGF20 protein, human
2
Drug Therapy
2
samital
1
regramostim
1
peppermint oil
1
meclocycline
1
hydrated silica gel-based toothpaste
1
holy basil leaf extract
1
cobiprostone
1
clazakizumab
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Xylitol
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Stomatitis
×
Lidocaine
×
Clear all
NCT02606994
2019-02-06
TPvsM
Oral Defense, LLC
Phase 2
Terminated
1 enrolled